| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 4 | |
| #2 | EPO (European Patent Office) | 3 | |
| #3 | China | 2 | |
| #4 | Israel | 2 | |
| #5 | New Zealand | 2 | |
| #6 | Canada | 1 | |
| #7 | Hong Kong | 1 | |
| #8 | Japan | 1 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Environmental technology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Microorganisms | |
| #3 | Medical preparations | |
| #4 | Peptides | |
| #5 | Climate change adaptation technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Mandl Stefanie | 12 |
| #2 | Delcayre Alain | 10 |
| #3 | Rountree Ryan | 7 |
| #4 | Foy Susan | 5 |
| #5 | Laus Reiner | 4 |
| #6 | Rountree Ryan Blair | 4 |
| #7 | Legrand Fatema | 2 |
| #8 | Franzusoff Alex | 2 |
| #9 | Leach Dana | 1 |
| #10 | Karlsson Gunilla | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2015069571A1 | Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor | |
| NZ601827A | Use of mva to treat prostate cancer |